Terms: = Uterine cancer AND CBL, RNF55, 867, ENSG00000110395, C-CBL, CBL2 AND Prognosis
2 results:
1. Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Pautier P; Floquet A; Chevreau C; Penel N; Guillemet C; Delcambre C; Cupissol D; Selle F; Isambert N; Piperno-Neumann S; Thyss A; Bertucci F; Bompas E; Alexandre J; Collard O; Lavau-Denes S; Soulié P; Toulmonde M; Le Cesne A; Lacas B; Duffaud F;
Lancet Oncol; 2015 Apr; 16(4):457-64. PubMed ID: 25795402
[TBL] [Abstract] [Full Text] [Related]
2. Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure.
Pietras RJ; Szego CM; Mangan CE; Seeler BJ; Burtnett MM; Orevi M
Obstet Gynecol; 1978 Sep; 52(3):321-7. PubMed ID: 703988
[TBL] [Abstract] [Full Text] [Related]
